Lindbrook Capital, LLC Takeda Pharmaceutical CO LTD Transaction History

Lindbrook Capital, LLC

  • $1.18 Billion
  • Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Lindbrook Capital, LLC holds 3,122 shares of TAK stock, worth $41,709. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,122
Previous 2,595 20.31%
Holding current value
$41,709
Previous $33,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$13.0 - $15.08 $6,851 - $7,947
527 Added 20.31%
3,122 $44,000
Q2 2024

Jul 31, 2024
SELL
$12.6 - $13.67 $22,680 - $24,606
-1,800 Reduced 40.96%
2,595 $33,000
Q1 2024

Apr 25, 2024
BUY
$13.89 - $15.04 $4,583 - $4,963
330 Added 8.12%
4,395 $61,000
Q4 2023

Jan 31, 2024
BUY
$13.36 - $15.43 $15,684 - $18,114
1,174 Added 40.61%
4,065 $58,000
Q3 2023

Oct 25, 2023
SELL
$15.03 - $16.32 $42,865 - $46,544
-2,852 Reduced 49.66%
2,891 $44,000
Q2 2023

Jul 28, 2023
SELL
$15.57 - $17.11 $27,045 - $29,720
-1,737 Reduced 23.22%
5,743 $90,000
Q1 2023

Apr 26, 2023
BUY
$15.28 - $16.48 $44,846 - $48,368
2,935 Added 64.58%
7,480 $123,000
Q4 2022

Jan 24, 2023
SELL
$12.42 - $15.62 $26,168 - $32,911
-2,107 Reduced 31.67%
4,545 $0
Q3 2022

Nov 10, 2022
BUY
$12.8 - $28.65 $8,038 - $17,992
628 Added 10.42%
6,652 $86,000
Q2 2022

Aug 01, 2022
SELL
$13.12 - $15.03 $15,993 - $18,321
-1,219 Reduced 16.83%
6,024 $85,000
Q1 2022

Apr 21, 2022
BUY
$13.54 - $15.35 $26,782 - $30,362
1,978 Added 37.57%
7,243 $104,000
Q4 2021

Jan 18, 2022
SELL
$13.17 - $16.4 $5,017 - $6,248
-381 Reduced 6.75%
5,265 $72,000
Q3 2021

Nov 05, 2021
BUY
$16.3 - $17.26 $4,987 - $5,281
306 Added 5.73%
5,646 $92,000
Q2 2021

Jul 27, 2021
SELL
$16.55 - $18.64 $27,737 - $31,240
-1,676 Reduced 23.89%
5,340 $90,000
Q1 2021

Apr 28, 2021
BUY
$16.71 - $19.9 $9,792 - $11,661
586 Added 9.11%
7,016 $128,000
Q4 2020

Jan 27, 2021
BUY
$15.39 - $18.97 $8,956 - $11,040
582 Added 9.95%
6,430 $117,000
Q3 2020

Nov 03, 2020
BUY
$17.1 - $19.19 $4,275 - $4,797
250 Added 4.47%
5,848 $104,000
Q2 2020

Jul 27, 2020
BUY
$14.59 - $19.5 $19,448 - $25,993
1,333 Added 31.25%
5,598 $100,000
Q1 2020

Apr 22, 2020
SELL
$13.02 - $20.31 $9,960 - $15,537
-765 Reduced 15.21%
4,265 $65,000
Q4 2019

Jan 27, 2020
SELL
$16.88 - $20.83 $13,115 - $16,184
-777 Reduced 13.38%
5,030 $99,000
Q3 2019

Oct 31, 2019
BUY
$16.15 - $17.99 $38,372 - $42,744
2,376 Added 69.25%
5,807 $100,000
Q2 2019

Jul 24, 2019
SELL
$16.58 - $20.49 $69,636 - $86,058
-4,200 Reduced 55.04%
3,431 $60,000
Q1 2019

Apr 23, 2019
BUY
$16.7 - $21.52 $127,437 - $164,219
7,631 New
7,631 $155,000

Others Institutions Holding TAK

# of Institutions
338
Shares Held
73.8M
Call Options Held
1.96M
Put Options Held
165K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email